14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 6 May 2024

Trading levels for CERS

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.13 31.28 %
R2 1.98 22.32 %
R1 1.89 16.78 %
Current price: 1.62
Support S1 1.60 -1.14 %
S2 1.51 -6.68 %
S3 1.37 -15.64 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.97 21.60 %
R2 1.86 14.81 %
R1 1.75 8.02 %
Current price 1.62
Support S1 0 .
S2 0 .
S3 0 .

CERS Predictions History

6 years ago
JS predicted that CERS for 2017-09-25 is going $2.59 (-0.38%)

6 years ago
JS predicted that CERS for 2017-08-07 is going $2.52 (1.82%)

6 years ago
eelika.sinisalu.7057 predicted that CERS for 2017-06-01 is going $2.98 (26.27%)

Rank:

7 years ago
JS predicted that CERS for 2017-04-10 is going $4.28 (1.66%)

7 years ago
OneTrickJohnny predicted that CERS for 2017-04-10 is going $4.34 (0.93%)

Rank:

7 years ago
JuanC Villegas predicted that CERS for 2017-04-10 is going $4.25 (-1.16%)

7 years ago
Mohammad.Hamzeh.1653 predicted that CERS for 2016-12-22 is going $3.63 (-16.93%)

Rank:

7 years ago
Kimberly.Erwin.198 predicted that CERS for 2016-05-23 is going $5.28 (1.54%)

Rank:
Click to get the best stock tips daily for free!

About Cerus Corporation

Cerus Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed t... CERS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT